So
Sorrento Ther
San Diego CAFounded 20091,500 employees
Private CapbiotechAcquiredOncologyCNS
Platform: Multimodal
Market Cap
N/A
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Lisonesiran | SOR-4708 | NDA/BLA | 2 | C5 | DLBCLAsthma | ||
| SOR-1685 | SOR-1685 | Phase 2 | 1 | PSMA | Prostate Ca |
Financial Documents
This company has been acquired — see parent company for financial filings.
Catalyst Events (3)